© 2002 European Society of Cardiology
Influence of progressive renal dysfunction in chronic heart failure
a Regional Nephrology Unit Belfast City Hospital, Belfast, Northern Ireland, UK
b Department of Medicine, Royal Victoria Hospital Grosvenor Road, Belfast BT12 6BA, Northern Ireland, UK
* Corresponding author. Tel.: +44-28-9089-4951; fax: +44-28-9026-3168. E-mail address: dp.nicholls{at}royalhospitals.n-i.nhs.uk
| Abstract |
|---|
Chronic heart failure (CHF) is often associated with impaired renal function due to hypoperfusion. Such patients are very sensitive to changes in renal perfusion pressure, and may develop acute tubular necrosis if the pressure falls too far. The situation is complicated by the use of diuretics, ACE inhibitors and spironolactone, all of which may affect renal function and potassium balance. Chronic renal failure (CRF) may also be associated with fluid overload. Anaemia and hypertension in CRF contribute to the development of left ventricular hypertrophy (LVH), which carries a poor prognosis, so correction of these factors is important.
Key Words: Chronic cardiac failure Chronic renal failure
Received September 4, 2001; Revised October 24, 2001; Accepted October 29, 2001
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
G. Cotter, M. Metra, O. Milo-Cotter, H. C. Dittrich, and M. Gheorghiade Fluid overload in acute heart failure -- Re-distribution and other mechanisms beyond fluid accumulation Eur J Heart Fail, February 1, 2008; 10(2): 165 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Greenberg, I. Thomas, D. Banish, S. Goldman, E. Havranek, B. M. Massie, Y. Zhu, B. Ticho, and W. T. Abraham Effects of Multiple Oral Doses of an A1 Adenosine Antagonist, BG9928, in Patients With Heart Failure: Results of a Placebo-Controlled, Dose-Escalation Study J. Am. Coll. Cardiol., August 14, 2007; 50(7): 600 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Juhlin, S. Bjorkman, and P. Hoglund Cyclooxygenase inhibition causes marked impairment of renal function in elderly subjects treated with diuretics and ACE-inhibitors Eur J Heart Fail, October 1, 2005; 7(6): 1049 - 1056. [Abstract] [Full Text] [PDF] |
||||
![]() |
Endorsed by the European Society of Intensive Care, Authors/Task Force Members, M. S. Nieminen, M. Bohm, M. R. Cowie, H. Drexler, G. S. Filippatos, G. Jondeau, Y. Hasin, J. Lopez-Sendon, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology Eur. Heart J., February 2, 2005; 26(4): 384 - 416. [Full Text] [PDF] |
||||
![]() |
M. R. Mehra, P. A. Uber, and G. S. Francis Heart failure therapy at a crossroad: are there limits to the neurohormonal model? J. Am. Coll. Cardiol., May 7, 2003; 41(9): 1606 - 1610. [Abstract] [Full Text] [PDF] |
||||


